Avemar North America

Avemar North America is the primary distributor of Avemar, a specialized fermented wheat germ extract (FWGE), in the United States and Canada. The company markets Avemar as a medical food and dietary supplement intended to support the immune system and metabolic health of patients with cancer and autoimmune diseases. Developed by Hungarian scientists, the product is supported by extensive clinical research demonstrating its ability to inhibit tumor cell metabolism and modulate immune responses. Avemar North America provides access to various formulations of the extract, including the concentrated AvéULTRA, to both healthcare professionals and consumers. The company emphasizes an evidence-based approach, citing numerous peer-reviewed studies that validate the extract's role in improving quality of life and clinical outcomes. By maintaining a focus on this single, highly-researched compound, the company has established itself as a leader in the oncology-supportive nutraceutical space.